Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrates improved immune response and… EP News Bureau Aug 18, 2021 Pre-clinical study provides evidence for improved immune responses with second-generation mRNA backbone jointly developed by…
